Agilent Shares Climb 5 Percent On 5-Percent Fiscal Q4 Revenue Gain and Decreased Profits | GenomeWeb

NEW YORK, Nov. 15 (GenomeWeb News) - Shares in Agilent were up 5.14 percent, or $1.69, at $34.59 in mid-afterbnoon tradiong after the company said revenue from its Bio-Analytical Measurement segmen grew nearly 10 percent during its fiscal fourth quarter.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.